Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin 3 IU versus 5 IU for elective caesarean section under spinal anaesthesia
ACTRN12616000398404Phase 4Completed
- Sponsor
- Royal Hobart Hospital
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Royal Hobart Hospital. Primary endpoint: Twenty four hour postpartum blood loss. Started Jul 2011; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12616000398404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000398404.